Junko Nagai

5PUBLICATIONS
5CO-AUTHORS
Molecular targetsToxicology (incl. clinical toxicology)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 13, 2025
Tumor-specific cytotoxicity of pyrazole-based chalcone derivatives in human oral squamous cell carcinoma cell lines.

Mehtap Tuğrak Sakarya, Halise İnci Gül, Hiroshi Sakagami

|Dec 02, 2021
Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database.

Junko Nagai, Yoichi Ishikawa

|Aug 30, 2020
Development of Newly Synthesized Chromone Derivatives with High Tumor Specificity against Human Oral Squamous Cell Carcinoma.

Yoshiaki Sugita, Koichi Takao, Yoshihiro Uesawa

|Apr 04, 2019
QSAR Prediction Model to Search for Compounds with Selective Cytotoxicity Against Oral Cell Cancer.

Junko Nagai, Mai Imamura, Hiroshi Sakagami

|Dec 27, 2018
Recent Progress of Basic Studies of Natural Products and Their Dental Application.

Hiroshi Sakagami, Taihei Watanabe, Tomonori Hoshino

Pageof 1

Frequent Collaborators

4 joint publications

Yoshihiro Uesawa

2 joint publications

Hiroshi Sakagami

1 joint publications

Mehtap Tuğrak Sakarya

1 joint publications

Halise İnci Gül